Interpace Biosciences (OTCMKTS:IDXG) Trading 16% Higher – What’s Next?
by Danessa Lincoln · The Markets DailyInterpace Biosciences, Inc. (OTCMKTS:IDXG – Get Free Report)’s stock price traded up 16% on Thursday . The company traded as high as $2.40 and last traded at $2.30. 10,221 shares were traded during trading, an increase of 164% from the average session volume of 3,870 shares. The stock had previously closed at $1.9824.
Interpace Biosciences Price Performance
The stock has a market cap of $10.19 million, a P/E ratio of -115.00 and a beta of 0.97. The business’s 50-day simple moving average is $1.81 and its two-hundred day simple moving average is $1.35.
About Interpace Biosciences
Interpace Biosciences, Inc provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer.